The double blind study of the clinical effects of anti-cholinergic agent "imidafenadcin" for COPD patients.
Not Applicable
- Conditions
- COPD Chronic obstructive pulmonary disease
- Registration Number
- JPRN-UMIN000005543
- Lead Sponsor
- Graduate School of Medical and Dental Sciences Kagoshima University Pulmonary Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded from participation if they corresponds to a contraindicated matter of imidafenacin(urinary retention, bowel obstruction, paralytic ileus, glaucoma, myasthenica gravis). The patient who is complicated with chronic respiratory desease except COPD. Patient having allergy to anticholinergic agent. The patient who has difficulty perform of the spirometry. In addition, the patient who judged that the examination medical attendant was inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method